No. 20-380

Idenix Pharmaceuticals LLC, et al. v. Gilead Sciences, Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

Reply of petitioners Universita Degli Studi di Cagliari filed. (Distributed)

DISTRIBUTED for Conference of 1/15/2021.

Motion to extend the time to file a response is granted and the time is extended to and including December 16, 2020.

Motion to extend the time to file a response from November 16, 2020 to December 16, 2020, submitted to The Clerk.

Response Requested. (Due November 16, 2020)

DISTRIBUTED for Conference of 10/30/2020.

Waiver of right of respondent Gilead Sciences, Inc. to respond filed.

Petition for a writ of certiorari filed. (Response due October 26, 2020)


Idenix Pharmaceuticals LLC, Petitioner, represented by Shay Dvoretzky

Universita Degli Studi di Cagliari, Petitioner, represented by Gregory Andrew Castanias

Gilead Sciences, Inc., Respondent, represented by E. Joshua Rosenkranz

Last updated: April 12, 2024